The role of IGF-binding proteins in mediating the effects of recombinant human IGF-I on insulin requirements in type 1 diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 8, 2001, Pages 3686-3691

  Crowne, E C ^a   Samra, J S ^c   Cheetham, T ^e   Acerini, C L ^b   Watts, A ^b   Holly, J M P ^d   Dunger, D B ^b  

^a BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c RADCLIFFE INFIRMARY   (United Kingdom)

^d BRISTOL ROYAL INFIRMARY   (United Kingdom)

^e ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; INSULIN; PLACEBO; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; CAPILLARY WALL; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS;

EID: 0034891376     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.8.7722     Document Type: Article

References (41)

1. Diabetes in puberty. Annotation
2. Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin?
3. Insulin therapy increases low plasma growth hormone binding protein in children with new onset type 1 diabetes
4. Somatomedin-C/IGF-I measured by radioimmunoassay and somatomedin bioactivity in adolescents with insulin dependent diabetes compared with puberty matched controls
5. Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes
6. Increased overnight growth hormone concentrations in diabetic compared with normal adolescents
7. The frequency and amplitude of growth hormone secretory episodes as determined by deconvolution analysis are increased in adolescents with insulin dependent diabetes mellitus and are unaffected by short term euglycaemia
8. The effects of recombinant insulin-like growth factor I administration on growth hormone levels and insulin requirements in adolescents with type 1 (insulin-dependent) diabetes mellitus
9. The effects of recombinant human insulin-like growth factor I on growth hormone secretion in adolescents with insulin dependent diabetes mellitus
10. Dual hormone replacement with insulin and recombinant human insulin-like growth factor-I in IDDM. Effects on glycaemic control, IGF-I levels and safety profile
11. Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus
12. Insulin-like growth factors in vitreous. Studies in control and diabetic subjects with neovascularization
13. Recombinant human insulin-like growth factor-I abolishes changes in insulin requirements consequent upon growth hormone pulsatility in young adults with type 1 diabetes mellitus
14. An unbiased glucose clamp method using a variable insulin infusion: Its application in diabetic adolescents
15. Control of pulsatile insulin secretion in man
16. The effects of repeated daily recombinant human insulin-like growth factor 1 administration in adolescents with type 1 diabetes
17. Effect of low-dose recombinant human insulin-like growth factor-1 on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus
18. Insulin-like growth factors: Studies in diabetics with and without retinopathy
19. Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: Effects on the growth hormone/IGF/IGF-binding protein system
20. The effect of insulin-like growth factor II on glucose uptake and metabolism in rat skeletal muscle in vitro
21. Insulin-like growth factor II stimulates glucose transport in human skeletal muscle
22. Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF-I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycaemia
23. Insulin-like growth factor-binding protein-2 and insulin: Studies in children with type 1 diabetes mellitus and maturity-onset diabetes of the young
24. Use of insulin-like growth factor-binding protein 2 (IGFBP-2), IGFBP-3 and IGF-I for assessing growth hormone status in short children
25. Insulin-like growth factor-I (IGF-I) infusion into hypophysectomized or protein-deproved rats induces specific IGF-binding proteins in serum
26. Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats
27. The effects of recombinant human insulin-like growth factor-1 (rhIGF-I) administration on the levels of IGF-I, IGF-II and IGF binding proteins in adolescents with insulin-dependent diabetes mellitus
28. Insulin-like growth factor-binding protein-1 modulates blood glucose levels
29. Insulin-like growth factor-binding protein-1: A role in glucose counterregulation?
30. The 'dawn phenomenon' in adolescents with insulin dependent diabetes mellitus: Possible contribution of insulin-like growth factor binding protein-1
31. The effects of subcutaneous insulin-like growth factor-I infusion in insulin-dependent diabetes mellitus
32. Responses of insulin-like growth factor-binding protein-1 (IGFBP-1) and the IGFBP-3 complex to administration of insulin-like growth factor-I
33. Regulation of growth hormone independent insulin-like growth factor-binding protein (BP-28) in cultured human fetal liver explants
34. Octreotide stimulates insulin-like growth factor-binding protein-1 levels in acromegaly
35. Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF-binding proteins in rat heart
36. Determination of the pharmacokinetic profiles of insulin-like growth factor binding proteins-1 and -2 in rats
37. Kidney IGF-I mRNA in initial renal hypertrophy in experimental diabetes in rats
38. Differential accumulation of insulin-like growth factor-I in kidneys of pre- and postpubertal streptozotocin-diabetic rats
39. Insulin like growth factors protect against diabetic neuropathy: Effects on sensory nerve regeneration in rats
40. Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycaemic control in type 1 diabetes
41. Normoglycaemic re-entry and diabetic complications